Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
04 feb 2015 - 08:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to present at 17th Annual BIO CEO & Investor Conference, New York City
Bericht
Probiodrug to present
at
17th Annual BIO CEO & Investor Conference,
New York City
HALLE/SAALE, Germany, 04 February 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Probiodrug's CEO and co-founder, Dr Konrad Glund, is scheduled to present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9th 2015 at 2.30pm EST. The conference will be held at the Waldorf Astoria Hotel in New York City.
Hosted by the Biotechnology Industry Organization (BIO), the BIO CEO & Investor Conference is now in its seventeenth year and is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.
Gerelateerde downloads
Datum laatste update: 31 juli 2025